Medical Care
Global Antibody Therapeutics and Blood Antibody Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 437730
- Pages: 96
- Figures: 95
- Views: 3
The global Antibody Therapeutics and Blood Antibody Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
By Type: (Dominant Segment vs High-Margin Innovation)
IgG1
IgG4
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Autoimmune
Tumor
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Roche in Europe)
- Emerging Product Trends: IgG1 adoption vs. IgG4 premiumization
- Demand-Side Dynamics: Autoimmune growth in China vs. Tumor potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Japan
China
Southeast Asia
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antibody Therapeutics and Blood Antibody Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., IgG4 in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Tumor in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Antibody Therapeutics and Blood Antibody Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Market Segmentation
By Company:
Roche
Abbvie
Johnson & Johnson
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Amgen
Biogen
UCB
Eli Lilly and Company
AstraZeneca
By Type: (Dominant Segment vs High-Margin Innovation)
IgG1
IgG4
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Autoimmune
Tumor
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Roche in Europe)
- Emerging Product Trends: IgG1 adoption vs. IgG4 premiumization
- Demand-Side Dynamics: Autoimmune growth in China vs. Tumor potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Japan
China
Southeast Asia
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antibody Therapeutics and Blood Antibody Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., IgG4 in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Tumor in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Antibody Therapeutics and Blood Antibody Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 IgG1
1.2.3 IgG4
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.3 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.4 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Antibody Therapeutics and Blood Antibody Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Antibody Therapeutics and Blood Antibody Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue
5.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Analysis
5.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
5.5 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics Head office and Area Served
5.6 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
5.7 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Japan Market: Players, Segments and Downstream
6.3.1 Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.3.2 Japan Market Size by Type
6.3.2.1 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.3.2.2 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.3.3 Japan Market Size by Application
6.3.3.1 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.3.3.2 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.3.4 Japan Market Trend and Opportunities
6.4 China Market: Players, Segments and Downstream
6.4.1 China Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.4.2 China Market Size by Type
6.4.2.1 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.4.2.2 China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.4.3 China Market Size by Application
6.4.3.1 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.4.3.2 China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.4.4 China Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
7 Key Players Profiles
7.1 Roche
7.1.1 Roche Company Details
7.1.2 Roche Business Overview
7.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.1.5 Roche Recent Development
7.2 Abbvie
7.2.1 Abbvie Company Details
7.2.2 Abbvie Business Overview
7.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.2.5 Abbvie Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Details
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.3.5 Johnson & Johnson Recent Development
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Details
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.4.5 Bristol-Myers Squibb Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.5.5 Novartis Recent Development
7.6 Merck
7.6.1 Merck Company Details
7.6.2 Merck Business Overview
7.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.6.5 Merck Recent Development
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Company Details
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.7.5 Alexion Pharmaceuticals Recent Development
7.8 Takeda
7.8.1 Takeda Company Details
7.8.2 Takeda Business Overview
7.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.8.5 Takeda Recent Development
7.9 Amgen
7.9.1 Amgen Company Details
7.9.2 Amgen Business Overview
7.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.9.5 Amgen Recent Development
7.10 Biogen
7.10.1 Biogen Company Details
7.10.2 Biogen Business Overview
7.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.10.5 Biogen Recent Development
7.11 UCB
7.11.1 UCB Company Details
7.11.2 UCB Business Overview
7.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.11.5 UCB Recent Development
7.12 Eli Lilly and Company
7.12.1 Eli Lilly and Company Company Details
7.12.2 Eli Lilly and Company Business Overview
7.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.12.5 Eli Lilly and Company Recent Development
7.13 AstraZeneca
7.13.1 AstraZeneca Company Details
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.13.5 AstraZeneca Recent Development
8 Antibody Therapeutics and Blood Antibody Therapeutics Market Dynamics
8.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Trends
8.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
8.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
8.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 IgG1
1.2.3 IgG4
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune
1.3.3 Tumor
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.3 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.4 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Antibody Therapeutics and Blood Antibody Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Antibody Therapeutics and Blood Antibody Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Antibody Therapeutics and Blood Antibody Therapeutics Revenue
5.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Analysis
5.4.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
5.5 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics Head office and Area Served
5.6 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
5.7 Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Japan Market: Players, Segments and Downstream
6.3.1 Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.3.2 Japan Market Size by Type
6.3.2.1 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.3.2.2 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.3.3 Japan Market Size by Application
6.3.3.1 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.3.3.2 Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.3.4 Japan Market Trend and Opportunities
6.4 China Market: Players, Segments and Downstream
6.4.1 China Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.4.2 China Market Size by Type
6.4.2.1 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.4.2.2 China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.4.3 China Market Size by Application
6.4.3.1 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.4.3.2 China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.4.4 China Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
7 Key Players Profiles
7.1 Roche
7.1.1 Roche Company Details
7.1.2 Roche Business Overview
7.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.1.4 Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.1.5 Roche Recent Development
7.2 Abbvie
7.2.1 Abbvie Company Details
7.2.2 Abbvie Business Overview
7.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.2.4 Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.2.5 Abbvie Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Details
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.3.4 Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.3.5 Johnson & Johnson Recent Development
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Details
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.4.4 Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.4.5 Bristol-Myers Squibb Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.5.4 Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.5.5 Novartis Recent Development
7.6 Merck
7.6.1 Merck Company Details
7.6.2 Merck Business Overview
7.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.6.4 Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.6.5 Merck Recent Development
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Company Details
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.7.4 Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.7.5 Alexion Pharmaceuticals Recent Development
7.8 Takeda
7.8.1 Takeda Company Details
7.8.2 Takeda Business Overview
7.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.8.4 Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.8.5 Takeda Recent Development
7.9 Amgen
7.9.1 Amgen Company Details
7.9.2 Amgen Business Overview
7.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.9.4 Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.9.5 Amgen Recent Development
7.10 Biogen
7.10.1 Biogen Company Details
7.10.2 Biogen Business Overview
7.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.10.4 Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.10.5 Biogen Recent Development
7.11 UCB
7.11.1 UCB Company Details
7.11.2 UCB Business Overview
7.11.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.11.4 UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.11.5 UCB Recent Development
7.12 Eli Lilly and Company
7.12.1 Eli Lilly and Company Company Details
7.12.2 Eli Lilly and Company Business Overview
7.12.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.12.4 Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.12.5 Eli Lilly and Company Recent Development
7.13 AstraZeneca
7.13.1 AstraZeneca Company Details
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Introduction
7.13.4 AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
7.13.5 AstraZeneca Recent Development
8 Antibody Therapeutics and Blood Antibody Therapeutics Market Dynamics
8.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Trends
8.2 Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
8.3 Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
8.4 Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Antibody Therapeutics and Blood Antibody Therapeutics Application
Table 18. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Table 21. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
Table 25. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. China Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. China Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 50. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Abbvie Company Details
Table 53. Abbvie Business Overview
Table 54. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 55. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Abbvie Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 60. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 65. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 70. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 75. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Alexion Pharmaceuticals Company Details
Table 78. Alexion Pharmaceuticals Business Overview
Table 79. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 80. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Alexion Pharmaceuticals Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 85. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Takeda Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 90. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Biogen Company Details
Table 93. Biogen Business Overview
Table 94. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 95. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. UCB Company Details
Table 98. UCB Business Overview
Table 99. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 100. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 101. UCB Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 105. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Eli Lilly and Company Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 110. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 111. AstraZeneca Recent Development
Table 112. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
Table 113. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
Table 114. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
Table 115. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Therapeutics and Blood Antibody Therapeutics Product Picture
Figure 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. IgG1 Features
Figure 4. IgG4 Features
Figure 5. Others Features
Figure 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2024 VS 2031
Figure 7. Autoimmune
Figure 8. Tumor
Figure 9. Others
Figure 10. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
Figure 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2024
Figure 20. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
Figure 22. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 23. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 24. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 25. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 26. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 27. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 28. China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 29. China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 30. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 31. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 32. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 33. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 34. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 35. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 37. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 38. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 39. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 40. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 41. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 42. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 43. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 44. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Table 1. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Antibody Therapeutics and Blood Antibody Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Antibody Therapeutics and Blood Antibody Therapeutics Application
Table 18. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Table 21. Ranking of Global Top Antibody Therapeutics and Blood Antibody Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Product and Application
Table 25. Global Key Players of Antibody Therapeutics and Blood Antibody Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. China Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. China Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 50. Roche Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Abbvie Company Details
Table 53. Abbvie Business Overview
Table 54. Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 55. Abbvie Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 56. Abbvie Recent Development
Table 57. Johnson & Johnson Company Details
Table 58. Johnson & Johnson Business Overview
Table 59. Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 60. Johnson & Johnson Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Johnson & Johnson Recent Development
Table 62. Bristol-Myers Squibb Company Details
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 65. Bristol-Myers Squibb Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 70. Novartis Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 75. Merck Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Alexion Pharmaceuticals Company Details
Table 78. Alexion Pharmaceuticals Business Overview
Table 79. Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 80. Alexion Pharmaceuticals Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Alexion Pharmaceuticals Recent Development
Table 82. Takeda Company Details
Table 83. Takeda Business Overview
Table 84. Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 85. Takeda Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Takeda Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 90. Amgen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Biogen Company Details
Table 93. Biogen Business Overview
Table 94. Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 95. Biogen Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Biogen Recent Development
Table 97. UCB Company Details
Table 98. UCB Business Overview
Table 99. UCB Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 100. UCB Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 101. UCB Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 105. Eli Lilly and Company Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 106. Eli Lilly and Company Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product
Table 110. AstraZeneca Revenue in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025) & (US$ Million)
Table 111. AstraZeneca Recent Development
Table 112. Antibody Therapeutics and Blood Antibody Therapeutics Market Trends
Table 113. Antibody Therapeutics and Blood Antibody Therapeutics Market Drivers
Table 114. Antibody Therapeutics and Blood Antibody Therapeutics Market Challenges
Table 115. Antibody Therapeutics and Blood Antibody Therapeutics Market Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Therapeutics and Blood Antibody Therapeutics Product Picture
Figure 2. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. IgG1 Features
Figure 4. IgG4 Features
Figure 5. Others Features
Figure 6. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application: 2024 VS 2031
Figure 7. Autoimmune
Figure 8. Tumor
Figure 9. Others
Figure 10. Antibody Therapeutics and Blood Antibody Therapeutics Report Years Considered
Figure 11. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Players in 2024
Figure 20. Global Top Antibody Therapeutics and Blood Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutics and Blood Antibody Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Antibody Therapeutics and Blood Antibody Therapeutics Revenue in 2024
Figure 22. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 23. North America Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 24. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 25. Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 26. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 27. Japan Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 28. China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 29. China Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 30. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Type (2020-2025)
Figure 31. Southeast Asia Antibody Therapeutics and Blood Antibody Therapeutics Market Share by Application (2020-2025)
Figure 32. Roche Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 33. Abbvie Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 34. Johnson & Johnson Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 35. Bristol-Myers Squibb Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 36. Novartis Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 37. Merck Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 38. Alexion Pharmaceuticals Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 39. Takeda Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 40. Amgen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 41. Biogen Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 42. UCB Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 43. Eli Lilly and Company Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 44. AstraZeneca Revenue Growth Rate in Antibody Therapeutics and Blood Antibody Therapeutics Business (2020-2025)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232